The next round of tests and appointments will be in April, so we will update the blog after that round.
Thank you for your continued prayers and support!
The Lantz Family
#carolinestrong
#ftgf
Fresh batch of DFMO!
Parent view of the CT Scan
November 2017: diagnosed with Stage IV, High-Risk Neuroblastoma; Nov 2017-April 2019: completed standard treatment protocol / no evidence of disease; April 2019-April 2021: enrolled in/completed DFMO clinical trial; April 2022: RELAPSE; April 2022-June 2023: completed relapse treatment protocol / no evidence of disease (again); June 2023-June 2024: enrolled in “compassionate use” high-dose DFMO clinical trial; June 2024: RELAPSE #2
Wednesday, December 2, 2020
CT Scan Results
Caroline had her follow-up CT scan today, and the results where all good! The scan showed no issues with the spot that appeared on her liver during her October scans. She remains NED (no evidence of disease) and will continue taking the clinical trial drug, DFMO, until April 2021.
Subscribe to:
Posts (Atom)